How much does Pitobrutinib/Pitobrutinib cost? Price inquiry is effortless!
Pirtobrutinib is a novel Bruton's tyrosine kinase (BTK) inhibitor , mainly used to treat certain types of hematological tumors, including relapsed or refractory mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL) . Its importance lies in the fact that it provides a new treatment option for patients who have developed resistance to or failed to benefit from traditional BTK inhibitors such as ibrutinib. This drug achieves anti-tumor effects by selectively inhibiting BTK and interfering with B cell signaling. In clinical trials, pitobrutinib has shown good efficacy and tolerability, especially in patients whose disease has progressed despite multiple treatment regimens, showing a high objective response rate.

For patients who wish to use this medication, it is important to understand the different versions and their prices. Currently, the original drug Pitobrutinib has been launched in China, but it has not yet been included in medical insurance. The price of 100mg*14 tablets*4 tablets per box may be more than 40,000 yuan. In overseas markets, the original drug of Pitobrutinib is available in European version and American version. The common specifications are 50mg*30 tablets and 100mg*60 tablets. The selling price of these drugs is usually close to 100,000 yuan, which is a considerable financial burden for most patients.
It is worth noting that although the original drug is expensive, there are also generic versions of pitobrutinib on the market. The ingredients of these generic drugs are basically the same as those of the original drugs. For example, the 50mg 30 tablets produced by a Lao pharmaceutical factory may be sold for more than 2,000 yuan. Since drug prices are affected by exchange rates, patients should pay attention to the latest market conditions when purchasing to ensure they get the best price.
Reference materials:https://go.drugbank.com/drugs/DB17472
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)